Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The mystery behind China's aggressive push into space
- What would a U.S.-Russia war look like?
- The best places to find love — and lust — according to science
- Here's the schedule very successful people follow every day
- Sex can't explain the culture war
- Why GOP reformers are bound to fail
- How the battle for religious freedom became a nonsensical free-for-all
- The 5 best and worst states for a well-lived life
- Boyhood's refreshingly unsentimental take on motherhood
- What religious traditionalists can teach us about sex
Subscribe to the Week